Global Intravenous IV Fluid Bags Market Size, Share, Growth Analysis, By Fluid Type(Total Parenteral Nutrients, Peripheral Parenteral Nutrition), By Nutrients(Carbohydrates, Vitamins) - Industry Forecast 2022-2028

Global Intravenous IV Fluid Bags Market was valued at USD 1.7 billion in 2021 and it is expected to reach at USD 3.49 billion by 2028, at a CAGR of 10.86% over the forecast period (2022-2028).

Medical fluid bags are constructed of an internal pouch and an exterior plastic coating and available in a variety of sizes. Up until the projected expiration date printed on the bags, the fluids are safeguarded by the compartmentalization of these bags into an inner pouch and an exterior coating. These bags are widely used in medical facilities with a multipurpose approach to maintain adequate sterilised conditions for the blood samples that help in ensuring infection-free premises, limiting the spread of disease, and preventing any loss of blood samples or pharmaceuticals.These bags are also used in fluid replacement therapy, which ensures accurate body fluid collection, blood transfusions, correction of electrolyte imbalances, and maintenance of the patient's appropriate nutritional intake via an oral or enteral route of delivery.

End-users are using disposable IV fluid bags more frequently in an effort to reduce healthcare expenditures and avoid hospital acquired infections and cross-contamination. Also, they are gaining popularity at blood bank facilities in order to meet the demand for emergency blood infusions as well as to treat other blood-borne disorders. Furthermore, PVC-free bags composed of non-latex components are being manufactured by IV fluid bag producers to deliver IV fluids precisely and safely.

Moreover, bespoke combinations that are cold, frozen, or both can be kept in these fluid bags. As a result, the market is anticipated to expand in the next years as a result of both an increase in innovations and a growing preference for IV fluid bags over traditional IV bags.

Top-down and bottom-up approaches were used to estimate and validate the size of Asia Pacific Intravenous IV Fluid Bags Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global Intravenous IV fluid bags market is segmented based on fluid type, nutrient, and region. Based on fluid type, the market is segmented into total parenteral nutrition and peripheral parenteral nutrition. On the basis of nutrient, the market can be bifurcated into carbohydrates, vitamins and minerals, single dose amino acids, parenteral liquid emulsion segments. The regional insights of the market are into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.

Driver

The older population is contributing to the global growth of the intravenous fluid bags market. Many disorders associated with ageing necessitate the adoption of efficient drug administration methods. Medications given intravenously are preferred to those given orally since the former results in more rapid and precise results. The preference for intravenous fluid administration is anticipated to increase with more consumer knowledge, and this will promote market expansion over the course of the anticipated period.

Restraint

The IV bag market may suffer as a result of the risk of infection and vein collapse brought on by the needle remaining in place for an extended period of time. Inadequate monitoring of intravenous therapy can potentially result in nutrient imbalances in the patient's body.

The availability of substitutes, such as plastic bottles, glass bottles, and infusion pumps to regulate the flow of solution into veins, may be a hindrance to the IV fluid bags industry. An electrolyte solution of this size, which is generally produced in IV bags of the customary 1 litre size, should not be introduced to children.

Market Trends

The rising prevalence of different chronic conditions, including diabetes, cancer, cardiovascular diseases, kidney infections, and liver disorders, is one of the key reasons driving the growth of the medical fluid bags market globally. A further factor driving industrial expansion is the rise in gastrointestinal illnesses, particularly in the senior population. Patients' health may be negatively impacted by the usage of PVC-based medical fluid bags, and the environment may suffer from incorrect disposal. The growth of the market can be slowed by these problems. The globalisation of hospitals and the healthcare sector, on the other hand, has led to a large rise in the usage of intravenous fluid bags.